1. NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones.
- Author
-
Favaron M, Manev RM, Rimland JM, Candeo P, Beccaro M, and Manev H
- Subjects
- Animals, Brain-Derived Neurotrophic Factor, Cells, Cultured, Cerebellum cytology, Cerebellum drug effects, Cycloheximide pharmacology, Cytoplasmic Granules metabolism, Dizocilpine Maleate pharmacology, Glutamates metabolism, Glutamic Acid, Neurons drug effects, Neurotransmitter Agents pharmacology, Potassium Chloride pharmacology, Rats, Rats, Sprague-Dawley, Stimulation, Chemical, Cerebellum metabolism, N-Methylaspartate pharmacology, Nerve Growth Factors biosynthesis, Nerve Tissue Proteins biosynthesis, Neurons metabolism, RNA, Messenger biosynthesis
- Abstract
The brain-derived neurotrophic factor (BDNF) affects the developing cerebellar granule cells. Exposure of 9-11-day-old primary cultures of rat cerebellar granule neurones for 3 h to a more depolarizing medium (additional 15-30 mM KCl) stimulated the release of glutamate and increased the BDNF mRNAs levels. This BDNF and mRNA upregulation was inhibited by dizocilpine (MK-801), the noncompetitive blocker of N-methyl-D-aspartate (NMDA)-sensitive glutamate receptors, and mimicked by NMDA. Continuous (up to 5 h) culture exposure to non-toxic NMDA concentration resulted in a prolonged increase in BDNF mRNA expression and enhanced neuronal resistance to glutamate toxicity. The latter effect of NMDA was attenuated by cycloheximide, a protein synthesis inhibitor. The mechanisms responsible for NMDA-triggered BDNF upregulation and neuroprotection might be important in the compensatory response of brain to excitotoxicity.
- Published
- 1993